ARTEMIS MEDICARE SERVICES LIMITED Financials Artemis Medicare Services Limited
Equities
ARTEMISMED
INE025R01021
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 191.9 INR | +0.08% |
|
+7.39% | +6.52% |
Valuation
| Fiscal Period: März | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 9,107 | 26,274 | - | - |
| Enterprise Value (EV) 1 | 9,107 | 23,076 | 26,274 | 26,274 |
| P/E ratio | 24.3 x | 48.1 x | 31 x | 19.6 x |
| Yield | - | - | - | - |
| Capitalization / Revenue | - | 2.63 x | 1.92 x | 1.42 x |
| EV / Revenue | - | 2.63 x | 1.92 x | 1.42 x |
| EV / EBITDA | - | 22.8 x | 12.8 x | 8.13 x |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | 5.27 x | 4.71 x | 3.82 x |
| Nbr of stocks (in thousands) | 134,119 | 136,916 | - | - |
| Reference price 2 | 67.90 | 191.9 | 191.9 | 191.9 |
| Announcement Date | 5/5/23 | 5/10/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Maart | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | 8,786 | 13,690 | 18,450 |
| EBITDA 1 | - | 1,011 | 2,050 | 3,230 |
| EBIT | - | - | - | - |
| Operating Margin | - | - | - | - |
| Earnings before Tax (EBT) 1 | - | 684.5 | 1,070 | 1,710 |
| Net income 1 | 386 | 491.4 | 850 | 1,330 |
| Net margin | - | 5.59% | 6.21% | 7.21% |
| EPS 2 | 2.790 | 3.530 | 6.200 | 9.800 |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share | - | - | - | - |
| Announcement Date | 5/5/23 | 5/10/24 | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: März | 2024 Q3 | 2024 Q4 |
|---|---|---|
| Net sales 1 | 2,340 | 2,440 |
| EBITDA | - | - |
| EBIT | - | - |
| Operating Margin | - | - |
| Earnings before Tax (EBT) | - | - |
| Net income | - | 496 |
| Net margin | - | 20.33% |
| EPS | - | - |
| Dividend per Share | - | - |
| Announcement Date | - | - |
1INR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: März | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt | - | - | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | 11.5% | 15% | 20% |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share 2 | - | 32.20 | 40.70 | 50.20 |
| Cash Flow per Share | - | - | - | - |
| Capex | - | - | - | - |
| Capex / Sales | - | - | - | - |
| Announcement Date | 5/5/23 | 5/10/24 | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
191.9
INR
Average target price
229
INR
Spread / Average Target
+19.33%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +6.52% | 315M | |
| -18.52% | 16.6B | |
| +5.41% | 12.87B | |
| +3.98% | 11.78B | |
| +4.38% | 10.28B | |
| +28.07% | 8.6B | |
| -4.98% | 7.64B | |
| +6.76% | 6.82B | |
| +6.26% | 6.4B | |
| +46.39% | 4.58B |
- Stock Market
- Equities
- ARTEMISMED Stock
- Financials Artemis Medicare Services Limited